GlycoSHIELD: New Software Revolutionizes Drug Development

GlycoSHIELD transforms the way sugar chains on proteins are modeled, facilitating drug development with its fast, user-friendly, and energy-efficient algorithm, marking a significant stride in both green computing and medical research. Model of the sugar shield (green) on the GABAA receptor (grey) in a membrane (red) generated by GlycoSHIELD. Credit: Cyril Hanus, Inserm, University Paris-Cité

Scientists create an innovative technique for rapid prediction of the morphology of sugar coats on clinically relevant proteins.

Proteins play essential roles in cell survival and significantly impact the development and progression of diseases. To grasp their function in health and disease, scientists investigate proteins’ three-dimensional atomic configurations through experimental and computational techniques.

Over 75 percent of proteins present at the surface of our cells are covered by glycans. These sugar-like molecules form very dynamic protective shields around the proteins. However, the mobility and variability of the sugars make it difficult to determine how these shields behave, or how they influence the binding of drug molecules.

Mateusz Sikora, the project leader and head of the Dioscuri Centre for Modelling of Posttranslational Modifications, and his team in Krakow and partners at the Max Planck Institute of Biophysics in Frankfurt am Main, Germany, have addressed this challenge by using computers, working together with scientists at Inserm in Paris, Academia Sinica in Tapei and the University of Bremen. Their powerful new algorithm GlycoSHIELD enables a fast but realistic modeling of the sugar chains present on protein surfaces. Reducing computing hours and therefore power consumption by several orders of magnitude compared to conventional simulation tools, GlycoSHIELD paves the path toward green computing.

From thousands of hours to a few minutes

Protective glycan shields strongly influence how proteins interact with other molecules such as therapeutic drugs. For example, the sugar layer on the spike protein of the coronavirus hides the virus from the immune system by making it difficult for natural or vaccine-induced antibodies to recognize the virus. The sugar shields therefore play an important role in drug and vaccine development. Pharmaceutical research could benefit from routinely predicting their morphology and dynamics. Until now, however, forecasting the structure of sugar layers using computer simulations was only possible with expert knowledge on special supercomputers. In many cases, thousands or even millions of computing hours were required.

With GlycoSHIELD, Sikora’s team provides a fast, environmentally friendly open-source alternative. “Our approach reduces resources, computing time, and the technical expertise needed,” says Sikora. “Anyone can now calculate the arrangement and dynamics of sugar molecules on proteins on their personal computer within minutes, without the need of expert knowledge and high-performance computers. Furthermore, this new way of making calculations is very energy efficient.” The software can not only be used in research, but could also be helpful for the development of drugs or vaccines, for example in immunotherapy for cancer.

A jigsaw puzzle made of sugar

How did the team manage to achieve such a high increase in efficiency? The authors created and analyzed a library of thousands of most likely 3D poses of the most common forms of sugar chains on proteins found in humans and microorganisms. Using long simulations and experiments, they found that for a reliable prediction of glycan shields, it is sufficient that the attached sugars do not collide with membranes or parts of the protein.

The algorithm is based on these findings. “GlyoSHIELD users only have to specify the protein and the locations where the sugars are attached. Our software then puzzles them on the protein surface in the most likely arrangement,” explains Sikora. “We could reproduce the sugar shields of the spike protein accurately: they look exactly as what we see in the experiments!” With GlycoSHIELD it is now possible to supplement new as well as existing protein structures with sugar information. The scientists also used GlycoSHIELD to reveal the pattern of the sugars on the GABAA receptor, an important target for sedatives and anesthetics.

A success for the Dioscuri Centre

The Dioscuri Centres initiated by the Max Planck Society are intended to help strengthen and expand excellent research in Central and Eastern Europe. Since May 2023, Mateusz Sikora, formerly a postdoctoral researcher at the Max Planck Institute of Biophysics, has been receiving financial support in the bilaterally funded program as head of the Dioscuri Centre for Modelling of Posttranslational Modifications created at Jagiellonian University in Krakow, Poland.

Gerhard Hummer, Head of the Department of Theoretical Biophysics at the Max Planck Institute of Biophysics, supports him as his partner from Germany and also contributed to this work. After less than a year, Sikora has already scored a major success with his green algorithm and is helping to promote Poland as an attractive and competitive research location.

Reference: “Rapid simulation of glycoprotein structures by grafting and steric exclusion of glycan conformer libraries” by Yu-Xi Tsai, Ning-En Chang, Klaus Reuter, Hao-Ting Chang, Tzu-Jing Yang, Sören von Bülow, Vidhi Sehrawat, Noémie Zerrouki, Matthieu Tuffery, Michael Gecht, Isabell Louise Grothaus, Lucio Colombi Ciacchi, Yong-Sheng Wang, Min-Feng Hsu, Kay-Hooi Khoo, Gerhard Hummer, Shang-Te Danny Hsu, Cyril Hanus and Mateusz Sikora, 29 February 2024, Cell.
DOI: 10.1016/j.cell.2024.01.034